Month: May 2022

Dallas, Texas, May 11, 2022 (GLOBE NEWSWIRE) — Priority Aviation, Inc. (OTC Pink: PJET) (“PJET”) today addressed the company’s ongoing high-growth strategy within the prevailing market conditions.  CEO Steven Rash released an update discussing the company’s evolving plans.  The update is included in its entirety below: Dear Shareholders: As a serial entrepreneur with more years under my belt than I care to admit I live with an optimistic outlook of the future and nothing in the prevailing market has changed that. Maintaining a long-career as an entrepreneur has also required me to balance my optimism with a healthy dose of practicality. I have often spoken with investors throughout my career about the inverse relationship between time and investment.  With more investment, a business plan can be executed in a shorter period of...

BEVERLY, Mass. and TORONTO, May 11, 2022 (GLOBE NEWSWIRE) — In a press release issued earlier today by Hamilton Thorne Ltd. (TSX-V: HTL), we were informed the headline of the release should read “Hamilton Thorne to Announce Q1 2022 Financial Results and Hold Conference Call on May 19, 2022” instead of “Hamilton Thorne to Announce Q4 and Year End 2021 Financial Results and Hold Conference Call on May 19, 2022”. Complete corrected text follows. Hamilton Thorne to Announce Q1 2022 Financial Results and Hold Conference Call on May 19, 2022 Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three...

Vancouver, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) — Evolving Gold Corp. (the “Company”) advises it has refiled its December 31, 2021 interim financial statements following a review of the statements by the Company’s auditors.  The review was undertaken in conjunction with the Company’s filing of a Listing Statement with the Canadian Securities Exchange (CSE), as part of the Company’s proposed acquisition of Elephant Capital Corp. (see news release of October 29, 2021). There were no material changes to any disclosure within the financial statements or notes thereto. On behalf of the Board of Directors, Charles Jenkins Charles Jenkins, CEO cej@evolvinggold.com 604-688-9588

Coloplast announces the successful issuance of EUR 2.2 billion senior notes under its Euro Medium Term Note programme NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES. NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON IN ANY JURISDICTION WHERE RELEASE, PUBLICATION OR DISTRIBUTION TO SUCH PERSON IS RESTRICTED BY ANY LAW OR REGULATION APPLICABLE IN SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR ISSUE OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES. Coloplast has today raised EUR 2.2 billion in debt financing through the issuance by Coloplast Finance B.V., a newly formed subsidiary of Coloplast, (“Coloplast Finance“) of senior unsecured notes in...

Presentations to focus on CLEC-1, novel myeloid immune checkpoint target for cancer immunotherapy NANTES, France, May 11, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) has been invited to provide an update on its R&D programs in immuno-oncology at two dedicated international conferences in May and June. The Company’s broad presence in scientific cancer research events confirms its expertise in the highly attractive field of myeloid cells and macrophages, identified as poor prognostic factors in oncology and in immune escape mechanisms of cancer immunotherapies. Details of the OSE Immunotherapeutics presentations:Immuno-Oncology Summit Europe 2022May 23-25, London, UK, and OnlineDate and time of presentation: Monday, May 23rd at 11:00Myeloid Checkpoints: Validated and Novel Targets from...

Beter Bed Holding N.V. (BBH) – the Netherlands’ largest sleep specialist in retail, wholesale and B2B – held its 2022 Annual General Meeting (AGM) today. BBH is pleased to announce that all resolutions, including the 2021 financial statements and dividend proposal, were adopted. The AGM presentation as well as the voting results will be published on www.beterbedholding.com. DividendBBH has made significant progress on its revised strategy, as announced in May 2021. The continued strong performance over 2021 reflects the underlying strength of the strategic transformation. In light of the strength of the financial position and financial performance, the Management Board, with the approval from the Supervisory Board, resolved to amend the dividend policy to align it with BBH’s ambition for sustainable growth. Today, the AGM declared a dividend...